Search Login Register
trioctyl phosphine oxide
(TOPO)
Summary
689
relevant articles (29 outcomes,
136 trials/studies)
found for this Bio-Agent
Also Known As:
TOPO; tri-n-octylphosphine oxide; trioctylphosphine oxide
Key Diseases for which trioctyl phosphine oxide is
Relevant
-
Neoplasms (Cancer)
:
14 outcomes 41 studies in 275 results
-
Leukemia
:
3 outcomes 11 studies in 70 results
-
Poisoning
:
3 outcomes 5 studies in 32 results
-
Colorectal Neoplasms (Colorectal Cancer)
:
2 outcomes 5 studies in 15 results
-
Colonic Neoplasms (Colon Cancer)
:
2 outcomes 1 study in 11 results
Show All >>
Drugs Related to trioctyl phosphine oxide
-
Etoposide (VP 16)
-
irinotecan (Camptosar)
-
Topotecan (Hycamtin)
-
Doxorubicin (Adriamycin)
-
Anthracyclines
-
Mitoxantrone (Novantrone)
-
Messenger RNA (mRNA)
-
Antineoplastic Agents (Antineoplastics)
-
amonafide
-
Type I DNA Topoisomerases (Topoisomerase I)
Show All >>
Therapies Related to trioctyl phosphine oxide
-
Drug Therapy (Chemotherapy)
-
Remission Induction
-
Adrenalectomy
-
Aftercare (After-Treatment)
-
Adjuvant Chemotherapy
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.